CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade $ SingMedical - 5OTsg CFD

Market is not available at the moment

Market information is presented
as of 2023-09-21

  • Summary
Trading Conditions
Spread 0.011
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021226 %
Charges from full value of position ($-4.03)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021226%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000692 %
Charges from full value of position ($-0.13)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000692%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency SGD
Margin 5%
Stock exchange Singapore
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.392
Open* 0.397
1-Year Change* 28.9%
Day's Range* 0.392 - 0.397
52 wk Range 0.28-0.40
Average Volume (10 days) 1.36M
Average Volume (3 months) 37.61M
Market Cap 194.65M
P/E Ratio 13.24
Shares Outstanding 486.38M
Revenue 105.26M
EPS 0.03
Dividend (Yield %) 1.625
Beta 0.97
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Date Close Change Change (%) Open High Low
Dec 19, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
Dec 16, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
Dec 15, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
Dec 14, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Dec 9, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Dec 8, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Dec 6, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Dec 2, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Dec 1, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 29, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 28, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 25, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 22, 2022 0.392 0.010 2.62% 0.382 0.392 0.382
Nov 21, 2022 0.382 -0.005 -1.29% 0.387 0.387 0.382
Nov 18, 2022 0.387 0.000 0.00% 0.387 0.387 0.382
Nov 17, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Nov 16, 2022 0.387 0.000 0.00% 0.387 0.387 0.382
Nov 15, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Nov 11, 2022 0.382 0.000 0.00% 0.382 0.387 0.382
Nov 10, 2022 0.387 0.005 1.31% 0.382 0.387 0.382

$ SingMedical Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 100.84 87.34 94.672 85.069 68.001
Revenue 100.84 87.34 94.672 85.069 68.001
Cost of Revenue, Total 56.58 49.3 51.431 47.274 39.027
Gross Profit 44.26 38.04 43.241 37.795 28.974
Total Operating Expense 83.175 76.269 77.472 69.921 57.541
Selling/General/Admin. Expenses, Total 28.229 23.97 26.128 23.087 18.8
Interest Expense (Income) - Net Operating -0.03 -0.075 -0.1 -0.071 -0.059
Unusual Expense (Income) 1.142 3.15 0.146 0.062 0.04
Other Operating Expenses, Total -2.746 -0.076 -0.133 -0.431 -0.267
Operating Income 17.665 11.071 17.2 15.148 10.46
Interest Income (Expense), Net Non-Operating 0.405 -0.529 -1.016 -0.786 -0.977
Net Income Before Taxes 18.07 10.528 16.069 14.104 9.483
Net Income After Taxes 15.716 9.097 13.635 12.915 8.732
Minority Interest -0.108 -0.367 0.026 0.013 -0.233
Net Income Before Extra. Items 15.608 8.73 13.661 12.928 8.499
Net Income 15.608 8.73 13.661 12.928 8.499
Income Available to Common Excl. Extra. Items 15.608 8.73 13.661 12.928 8.499
Income Available to Common Incl. Extra. Items 15.608 8.73 13.661 12.928 8.499
Diluted Net Income 15.608 8.73 13.661 12.928 8.499
Diluted Weighted Average Shares 484.059 482.844 508.501 472.419 427.795
Diluted EPS Excluding Extraordinary Items 0.03224 0.01808 0.02687 0.02737 0.01987
Diluted Normalized EPS 0.0343 0.02372 0.02704 0.02716 0.01937
Other, Net 0 -0.014 -0.115 -0.258
Dividends per Share - Common Stock Primary Issue 0.0065 0.004 0.004
Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
Total revenue 51.158 49.682 48.395 38.945 25.856
Revenue 51.158 49.682 48.395 38.945 25.856
Cost of Revenue, Total 29.175 27.405 26.268 23.032 14.366
Gross Profit 21.983 22.277 22.127 15.913 11.49
Total Operating Expense 42.5 40.675 42.275 33.994 21.667
Selling/General/Admin. Expenses, Total 14.894 13.335 12.868 11.102 7.263
Interest Expense (Income) - Net Operating -0.011 -0.019 -0.015 -0.06 -0.034
Unusual Expense (Income) 0.011 -0.011 0.167 0.146
Other Operating Expenses, Total -1.569 -0.035 2.987 -0.08 -0.074
Operating Income 8.658 9.007 6.12 4.951 4.189
Interest Income (Expense), Net Non-Operating 0.468 -0.063 0.313 -0.856 0.084
Net Income Before Taxes 9.126 8.944 6.433 4.095 4.273
Net Income After Taxes 7.989 7.727 5.614 3.483 3.61
Minority Interest 0.429 -0.537 -0.338 -0.029 0.073
Net Income Before Extra. Items 8.418 7.19 5.276 3.454 3.683
Net Income 8.418 7.19 5.276 3.454 3.683
Income Available to Common Excl. Extra. Items 8.418 7.19 5.276 3.454 3.683
Income Available to Common Incl. Extra. Items 8.418 7.19 5.276 3.454 3.683
Diluted Net Income 8.418 7.19 5.276 3.454 3.683
Diluted Weighted Average Shares 485.474 482.644 482.947 482.741 506.48
Diluted EPS Excluding Extraordinary Items 0.01734 0.0149 0.01092 0.00715 0.00727
Dividends per Share - Common Stock Primary Issue 0.0065 0 0.004 0 0.004
Diluted Normalized EPS 0.01733 0.01487 0.01122 0.00713 0.00747
Other, Net 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 35.968 34.911 37.386 30.549 30.86
Cash and Short Term Investments 26.618 25.623 27.316 20.012 21.326
Cash 26.618 25.623 27.316 20.012 21.326
Total Receivables, Net 6.494 6.757 7.288 7.068 6.871
Accounts Receivable - Trade, Net 5.968 5.268 5.631 6.031 4.749
Total Inventory 1.961 1.828 1.8 1.694 1.521
Prepaid Expenses 0.895 0.703 0.982 1.775 1.142
Total Assets 201.837 190.538 197.618 181.844 167.631
Property/Plant/Equipment, Total - Net 19.639 16.657 20.749 13.652 13.506
Intangibles, Net 0.563 0.811 0.82 0.442 0
Long Term Investments 19.786 11.5 8.902 7.356 1.532
Note Receivable - Long Term 1.639 2.828 2.906 2.9 1.495
Other Long Term Assets, Total 0.829 0.73 0.754 0.844 1.039
Total Current Liabilities 26.471 29.368 40.67 37.804 33.518
Accounts Payable 2.075 1.886 2.12 1.648 1.912
Notes Payable/Short Term Debt 0 0 9.201 0 0
Current Port. of LT Debt/Capital Leases 6.298 10.441 11.589 6.219 3.21
Other Current Liabilities, Total 8.692 8.325 17.76 29.937 28.396
Total Liabilities 33.888 36.454 51.667 51.066 59.348
Total Long Term Debt 7.888 6.992 11.092 11.704 8.272
Long Term Debt 2.188 3.649 5.295 9.98 7.375
Capital Lease Obligations 5.7 3.343 5.797 1.724 0.897
Deferred Income Tax 0.532 0.259 0.228 0.17 0.103
Minority Interest -1.411 -0.573 -0.702 -0.45 0.05
Other Liabilities, Total 0.408 0.408 0.379 1.838 17.405
Total Equity 167.949 154.084 145.951 130.778 108.283
Common Stock 121.028 119.838 119.789 118.918 108.738
Retained Earnings (Accumulated Deficit) 47.594 33.243 26.246 12.502 -0.343
Other Equity, Total -0.623 -0.261 -0.042 -0.642 -0.112
Total Liabilities & Shareholders’ Equity 201.837 190.538 197.618 181.844 167.631
Total Common Shares Outstanding 486.382 482.61 482.882 459.415 459.416
Property/Plant/Equipment, Total - Gross 35.243 31.973 35.222 27.802 23.967
Accumulated Depreciation, Total -15.604 -15.316 -14.473 -14.15 -10.461
Goodwill, Net 123.413 123.101 126.101 126.101 119.199
Treasury Stock - Common -0.05 -0.089 -0.042
Accrued Expenses 9.406 8.716
Unrealized Gain (Loss) 0 1.353
Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
Total Current Assets 35.968 34.149 34.911 29.304 37.386
Cash and Short Term Investments 26.618 24.665 25.623 20.254 27.316
Cash 26.618 24.665 25.623 20.254 27.316
Total Receivables, Net 6.494 6.421 6.757 5.904 7.288
Accounts Receivable - Trade, Net 5.968 5.537 5.268 4.218 5.631
Total Inventory 1.961 1.864 1.828 2.09 1.8
Prepaid Expenses 0.895 1.199 0.703 1.056 0.982
Total Assets 201.837 188.331 190.538 192.079 197.618
Property/Plant/Equipment, Total - Net 19.639 15.669 16.657 23.118 20.749
Intangibles, Net 123.976 123.917 123.912 126.828 126.921
Long Term Investments 19.786 11.026 11.5 9.416 8.902
Note Receivable - Long Term 1.639 2.843 2.828 2.643 2.906
Other Long Term Assets, Total 0.829 0.727 0.73 0.77 0.754
Total Current Liabilities 26.471 24.42 29.368 33.046 40.67
Accounts Payable 2.075 1.981 1.886 2.436 2.12
Notes Payable/Short Term Debt 0 0 0 0 9.201
Current Port. of LT Debt/Capital Leases 6.298 7.653 10.441 10.54 11.589
Other Current Liabilities, Total 18.098 14.786 17.041 20.07 17.76
Total Liabilities 33.888 29.617 36.454 45.009 51.667
Total Long Term Debt 7.888 4.572 6.992 11.962 11.092
Long Term Debt 2.188 2.599 3.649 2.789 5.295
Capital Lease Obligations 5.7 1.973 3.343 9.173 5.797
Deferred Income Tax 0.532 0.366 0.259 0.295 0.228
Minority Interest -1.411 -0.149 -0.573 -0.673 -0.702
Other Liabilities, Total 0.408 0.408 0.408 0.379 0.379
Total Equity 167.949 158.714 154.084 147.07 145.951
Common Stock 121.028 119.888 119.838 119.836 119.789
Retained Earnings (Accumulated Deficit) 47.594 38.497 33.243 27.842 26.246
Treasury Stock - Common -0.05 -0.05 -0.089 -0.089 -0.042
Other Equity, Total -0.623 -0.39 -0.261 -0.519 -0.042
Total Liabilities & Shareholders’ Equity 201.837 188.331 190.538 192.079 197.618
Total Common Shares Outstanding 486.382 482.789 482.61 482.611 482.882
Unrealized Gain (Loss) 0 0.769 1.353
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 18.07 10.528 16.069 14.104 9.483
Cash From Operating Activities 24.467 20.907 26.109 17.44 12.788
Cash From Operating Activities 8.915 8.959 8.933 3.882 2.646
Non-Cash Items -1.794 2.444 1.527 1.174 1.008
Cash Interest Paid 0.488 1.199 1.003 0.76 0.471
Changes in Working Capital -1.177 -1.389 -0.665 -1.8 -0.349
Cash From Investing Activities -9.688 -3.365 -18.745 -28.682 -22.223
Capital Expenditures -4.229 -1.572 -2.143 -3.42 -5.014
Other Investing Cash Flow Items, Total -5.459 -1.793 -16.602 -25.262 -17.209
Cash From Financing Activities -13.784 -19.235 -0.06 9.953 22.937
Financing Cash Flow Items -1.063 -0.3 -0.38 -0.537 -0.627
Issuance (Retirement) of Stock, Net 0.553 -0.084 0.676 7.088 15.933
Issuance (Retirement) of Debt, Net -11.344 -16.921 -0.356 3.402 7.631
Net Change in Cash 0.995 -1.693 7.304 -1.289 13.502
Amortization 0.453 0.365 0.245 0.08 0
Cash Taxes Paid 2.018 1.418 1.888 0.924 0.091
Total Cash Dividends Paid -1.93 -1.93
Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
Net income/Starting Line 18.07 8.944 10.528 4.095 16.069
Cash From Operating Activities 24.467 9.8 20.907 9.794 26.109
Cash From Operating Activities 8.915 4.385 8.959 4.513 8.933
Amortization 0.453 0.187 0.365 0.168 0.245
Non-Cash Items -1.794 0.166 2.444 1.126 1.527
Cash Taxes Paid 2.018 1.671 1.418 0.057 1.888
Cash Interest Paid 0.488 0.278 1.199 0.806 1.003
Changes in Working Capital -1.177 -3.882 -1.389 -0.108 -0.665
Cash From Investing Activities -9.688 -3.194 -3.365 -0.928 -18.745
Capital Expenditures -4.229 -3.212 -1.572 -0.525 -2.143
Other Investing Cash Flow Items, Total -5.459 0.018 -1.793 -0.403 -16.602
Cash From Financing Activities -13.784 -7.564 -19.235 -15.928 -0.06
Financing Cash Flow Items -1.063 -0.16 -0.3 -0.38
Issuance (Retirement) of Stock, Net 0.553 0 -0.084 -0.084 0.676
Issuance (Retirement) of Debt, Net -11.344 -5.474 -16.921 -15.844 -0.356
Net Change in Cash 0.995 -0.958 -1.693 -7.062 7.304
Total Cash Dividends Paid -1.93 -1.93 -1.93

SingMedical Company profile

About Singapore Medical Group Ltd

Singapore Medical Group Limited is a Singapore-based company that is engaged in the operation of medical clinics, provision of general medical services and investment holdings. The Company operates through three segments. The Health Business segment consists of obstetrical and gynecological services; oncology services including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics Business segment consists of radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment, and aesthetics medicine services. Its Others segment consists of group-level corporate services as well as business consultancy functions and telemedicine services.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Singapore Medical Group Ltd revenues increased 15% to SP$100.8M. Net income increased 79% to SP$15.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Expense decrease of 74% to SP$159K (expense), Share of results of joint ventures and a increase of 98% to SP$898K (income).

Equity composition

01/2014, Rights Issue, 1 new shares for every 2 shares held @ 0.105 SGD (Factor: 1.058824).12/2014, Rights Issue, 1 new share for every 10 shares held @ SGD 0.153 Factor(1.0)

Industry: Healthcare Facilities & Services (NEC)

1004 Toa Payoh North
Floor 06 Unit 03 07
318995
SG

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

XRP/USD

0.52 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

ETH/USD

1,594.81 Price
+0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

US100

14,710.90 Price
+0.190% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

26,619.15 Price
+0.150% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading